comparemela.com

Page 8 - Medical Devices Agency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan

Supplemental cohort of 12 Japanese patients to be added to global Phase 3 hypothalamic obesity trial, with dosing expected to begin in third qu.

United statesUnited kingdomDavid connollyAdam daleyDavid meekerJapan pharmaceuticalsJapan ministry of healthDrug administrationCorporate communicationsEuropean unionBerry company public relationsRhythm pharmaceuticals incExchange commissionRhythm pharmaceuticalsEuropean commissionUnited kingdom medicines healthcare products regulatory agency

Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

15.02.2024 - Received 459 new patient start forms (PSFs) for FILSPARI (sparsentan) in Q4 2023; Total of 1,452 PSFs received in 2023 Company nearing submission of sNDA to convert U.S. accelerated approval of FILSPARI in IgAN to full approval .

Deric dubeDrug administrationEuropean unionDevices agencyProgram updatesCommittee for medicinal products human useRenalys pharma incTravere therapeutics incExchange commissionContinuing operationsQuarter ended decemberNew drug applicationMedicinal productsHuman useConditional marketing authorizationRenalys pharma

Robust Recovery: BridgeBio (BBIO) Shares Soar After-Market

An impressive rebound in BridgeBio (BBIO) stock, fueled by strategic collaborations, marking a resilient uptrend in after-market trading.

Devices agencyKyowa kirin coJapanese pharmaceuticalsBridgebio pharma incBridgebio pharmaKyowa kirinMedical devices agency

Marcos OKs pharma-zones for cheaper generics

Marcos OKs pharma-zones for cheaper generics
philstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philstar.com Daily Mail and Mail on Sunday newspapers.

United statesSamuel zacateJesusa joyce cirunayDrug administrationDevices agencyAssociation of southeast asian nationsJapan pharmaceuticalsPhilippine economic zone authorityPresident marcosMedical devices agencySoutheast asian

BridgeBio sells partial rights to dwarfism drug for $100M

The upfront payment pads BridgeBio’s balance sheet as the company gears up for the anticipated launch of another drug, ATTR-CM med acoramidas.

United statesYasuo fujiiNeil kumarUltragenyx pharmaDevices agencyKyowa kirinMedical devices agencyNorth american

vimarsana © 2020. All Rights Reserved.